Table3. Main effects analysis: odds ratios (OR) and 95% confidence interval (95% CI) for not undergoing curative treatment in men with prostate cancer diagnosed from 2002 to 2008, by age group.
|
Curative treatment |
|
|||||
|---|---|---|---|---|---|---|
| |
Yes |
No |
Univariate |
Gleason and tumour size adjusted |
Gleason, clinical stage and Charlson adjusted |
Multivariate adjusteda |
| Age group (years) | % | % | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) |
|
40–59 |
90.8 |
9.2 |
0.61 (0.48, 0.76) |
0.61 (0.49, 0.77) |
0.63 (0.50, 0.79) |
0.63 (0.50, 0.79) |
|
60–69 |
85.7 |
14.3 |
1.00 |
1.00 |
1.00 |
1.00 |
|
70–79 |
51.8 |
48.2 |
5.55 (4.76, 6.47) |
5.54 (4.75, 6.46) |
5.31 (4.54, 6.20) |
5.51 (4.70, 6.47) |
| 80+ | 8.3 | 91.7 | 66.09 (44.96, 97.15) | 64.49 (43.73, 95.12) | 59.14 (40.03, 87.39) | 57.57 (38.82, 85.39) |
a
ORs adjusted for year of incidence, tumour-related clinical variables (Gleason score, clinical stage), patient-related clinical variables (Charlson index) and socio-demographic variables (marital status, smoking status, and HSE area of residence).